|Articles|September 1, 2012

Realize Effective Pharmaceuticals

Reliable solutions enable pharmaceutical scientists to innovate in disease research, accelerate drug discovery and have greater confidence throughout development and manufacturing. Agilent solutions in genomics research, automation, separation and detection technologies along with workflow driven software solutions helps deliver the answers to bring effective therapeutics to market.

Realize Effective Pharmaceuticals

Learn more at www.agilent.com/lifesciences/realizepharma.

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Related to this article

Drug tablet and pill rotary press machine in in the lab ore medicine manufacturing factory health and hospital background concept. Рharmaceutical laboratory. | Image Credit: ©Dr.Bakl -stock.adobe.com

November 6th, 2026

CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing

Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.

November 6th, 2026

Supply Chain Excellence: Managing Temperature and Time Requirements for Ultra-Rare Therapies

Almac Clinical Services’ clinical supply strategy won the 2026 CPHI Award for Supply Chain Excellence. Nishma Patel, supply chain solutions manager, explains how her team managed the study’s strict −80 °C handling requirement, quality release, and site readiness, and how the Almac Adapt approach can apply beyond this program.

November 6th, 2026

PharmTech AI Pulse Check: Why Pharma's AI Compliance Doesn't End at Go-Live

The PharmTech AI Pulse Check panel discusses why MHRA and FDA oversight of pharma AI continues past go-live, and who validates the regulators' own AI.

Subcutaneous amivantamab wins head and neck cancer approval as IV-to-subcutaneous biologics expand.

November 6th, 2026

Why Amivantamab's Approval Matters to Formulators

The FDA grants accelerated approval to subcutaneous amivantamab for head and neck cancer, extending the IV-to-subcutaneous shift in biologics formulation.

Drug shortages now last 5+ years and the root cause isn’t on the manufacturing floor.

November 6th, 2026

Why Drug Shortages Average 5+ Years: PharmTech Explained

USP data show fewer US drug shortages but longer ones, averaging 5+ years. Drug shortages are an incentive problem, not a manufacturing mystery.

From ADCs to molecular glues, four licensing deals raise tech transfer stakes for manufacturers.

November 5th, 2026

ADCs, Degraders, Agonists: 4 Deals CMC Teams Should Track

Boehringer, AbbVie, ASKA, and Evommune license ADC, IBD, thyroid eye disease, and degrader assets, raising tech transfer demands for manufacturers.

November 5th, 2026

Supply Chain Excellence Through Just-in-Time Manufacturing

Almac Clinical Services’ clinical supply strategy won the 2026 CPHI Award for Supply Chain Excellence. Nishma Patel, supply chain solutions manager, explains the benefits and challenges of the company’s just-in-time manufacturing solution.

November 5th, 2026

PharmSci 360: Build the Device Into Dosage Form Development From Day One

Vivek Gupta of Duquesne University explains at AAPS PharmSci 360 why device decisions can't wait and why excipient makers must test beyond drug molecules.

Realize Effective Pharmaceuticals

Related to this article

Trending on Pharmaceutical Technology

Why Impurity Deficiencies Keep Repeating: AAPS PharmSci 360 2026

Drapeau’s AI Deep Dive: The Price of Acceptance in Regulated AI

Why Drug Shortages Average 5+ Years: PharmTech Explained

Expert Commentary on Formulation, Scale-Up, and Patient-Centered Design Found at CPHI Milan

ADCs, Degraders, Agonists: 4 Deals CMC Teams Should Track